Katriina Vuolteenaho

Activities

Activities per year 1999 2009 2010 2011 2012 2013 2016 2017 2018 2023

• 160 Conference presentation
• 16 Invited lecture
• 10 Reviewer of Scientific Journal
• 7 Position of trust in an academic community
• 22 More
  • 6 Regular membership of a society or network
  • 4 Pre-examination of dissertation or acting as opponent to doctoral students
  • 4 Supervisor of licentiate candidate in medicine
  • 2 Supervisor of doctoral candidate
  • 2 Supervisor of licentiate candidate
  • 2 Position of trust in a funding organization
  • 1 Statement of assessment of docentship
  • 1 Supervisor of master student

Activities per year

Search results

• MKP-1 as a novel anti-inflammatory drug target: cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1

  Lehtola, T. (Contributor), Nummenmaa, E. (Contributor), Leppänen, T. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  30 Nov 2023

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential (TRP) channel expression in human osteoarthritic chondrocytes - TRPA1 and TRPM8 as potential drug targets

  Halonen, L. (Contributor), Pemmari, A. (Contributor), Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  30 Nov 2023

  Activity: Talk or presentation › Conference presentation

• Myocardial MCP-1, IL-6 and E-Selectin expression is markedly increased in patients undergoing coronary artery bypass grafting surgery. A GWEA based pilot study.

  Laurikka, A. (Speaker), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Laurikka, J. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  30 Nov 2023

  Activity: Talk or presentation › Conference presentation

• Meteorin-like protein is a novel factor and potential drug target in osteoarthritis

  Vuolteenaho, K. (Contributor), Koskinen-Kolasa, A. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  30 Nov 2023

  Activity: Talk or presentation › Conference presentation

• Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets

  Laurikka, A. (Speaker), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Laurikka, J. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  2 Jul 2023 → 7 Jul 2023

  Activity: Talk or presentation › Conference presentation

• Meteorin-like protein as a novel factor and potential drug target in osteoarthritis

  Vuolteenaho, K. (Speaker), Koskinen-Kolasa, A. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  2 Jul 2023

  Activity: Talk or presentation › Conference presentation

• cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1 in murine macrophages

  Lehtola, T. (Contributor), Nummenmaa, E. (Contributor), Leppänen, T. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  2 Jul 2023 → 7 Jul 2023

  Activity: Talk or presentation › Conference presentation

• Human osteoarthritic chondrocytes express nineteen different TRP-genes – TRPA1 and TRPM8 as potential drug targets

  Halonen, L. (Speaker), Pemmari, A. (Contributor), Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  2 Jul 2023 → 7 Jul 2023

  Activity: Talk or presentation › Conference presentation

• Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets

  Laurikka, A. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Laurikka, J. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  22 Mar 2023 → 24 Mar 2023

  Activity: Talk or presentation › Conference presentation

• The glucocorticoid dexamethasone alleviates allergic inflammation through an MKP-1 dependent mechanism

  Lehtola, T. (Contributor), Nummenmaa, E. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  22 Mar 2023 → 24 Mar 2023

  Activity: Talk or presentation › Conference presentation

• Human osteoarthritic chondrocytes express nineteen different TRP-genes – TRPA1 and TRPM8 as potential drug targets

  Vuolteenaho, K. (Examiner)

  2023

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate

• Inflammatory glycoprotein YKL-40 is elevated after coronary artery bypass surgery and correlates with leukocyte chemotaxis and myocardial injury, a pilot study

  Laurikka, A. (Speaker), Vuolteenaho, K. (Contributor), Toikkanen, V. (Contributor), Rinne, T. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Tarkka, M. (Contributor), Laurikka, J. (Contributor) & Moilanen, E. (Contributor)

  24 Nov 2022 → 25 Nov 2022

  Activity: Talk or presentation › Conference presentation

• The glucocorticoid dexamethasone alleviates acute allergic inflammatory reaction through an MKP-1 dependent mechanism

  Lehtola, T. (Speaker), Nummenmaa, E. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  24 Nov 2022 → 25 Nov 2022

  Activity: Talk or presentation › Conference presentation

• Pinosylvin shifts macrophage polarization to support resolution of inflammation

  Vuolteenaho, K. (Examiner)

  2022

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate

• Pinosylvin shifts macrophage polarization to support resolution of inflammation

  Kivimäki, K. (Speaker), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  25 Nov 2021 → 26 Nov 2021

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a factor in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates fibroblast growth factor-2 expression in chondrocytes

  Nummenmaa, E. (Speaker), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  25 Nov 2021 → 26 Nov 2021

  Activity: Talk or presentation › Conference presentation

• Suomen Farmakologiyhdistys ry, johtokunnan jäsen (External organisation)

  Vuolteenaho, K. (Member)

  1 Jan 2021 → …

  Activity: Membership › Position of trust in an academic community

• Väitöskirjan esitarkastus

  Vuolteenaho, K. (Pre-examiner or opponent of dissertation)

  17 Apr 2020

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Suomen Farmakologiyhdistys ry, sihteeri (External organisation)

  Vuolteenaho, K. (Position of trust)

  1 Jan 2020 → 31 Dec 2020

  Activity: Membership › Position of trust in an academic community

• Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, E. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, T. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Pemmari, A. (Contributor), Tuure, L. (Contributor), Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  2 May 2019

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) as a factor and drug target in osteoarthritis: TRPA1 mediates fibroblast growth factor 2 expression in chondrocytes

  Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)

  2 May 2019

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates fibroblast growth factor-2 (FGF-2) expression in chondrocytes

  Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)

  20 Mar 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  20 Mar 2019

  Activity: Talk or presentation › Conference presentation

• Adipokines and disease activity in patients with newly diagnosed inflammatory joint diseases

  Kononoff, A. (Speaker), Vuolteenaho, K. (Speaker), Hämäläinen, M. (Speaker), Kautiainen, H. (Speaker), Elfving, P. (Speaker), Savolainen, E. (Speaker), Arstila, L. (Speaker), Niinisalo, H. (Speaker), Rutanen, J. (Speaker), Marjoniemi, O. (Speaker), Moilanen, E. (Speaker) & Kaipiainen-Seppänen, O. (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Pemmari, A. (Speaker), Tuure, L. (Speaker), Hämäläinen, M. (Speaker), Leppänen, T. (Speaker), Vuolteenaho, K. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes

  Nummenmaa, E. (Speaker), Hämäläinen, M. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker) & Vuolteenaho, K. (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• Pirkanmaan sairaanhoitopiirin kuntayhtymä, Tampereen yliopistollisen sairaalan erityisvastuualueen alueellinen eettinen toimikunta, jäsen (External organisation)

  Vuolteenaho, K. (Member)

  1 Jan 2019 → 12 Sept 2021

  Activity: Membership › Regular membership of a society or network

• Journal of Functional Foods (Journal)

  Vuolteenaho, K. (Reviewer)

  2019

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis

  Hämäläinen, M. (Contributor), Lehtimäki, L. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Nummenmaa, E. (Contributor) & Vuolteenaho, K. (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  Laavola, M. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor), Nieminen, R. (Contributor) & Moilanen, E. (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• Obesity and adipokines in osteoarthritis

  Vuolteenaho, K. (Keynote speaker)

  8 Sept 2018

  Activity: Talk or presentation › Invited lecture

• TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis

  Hämäläinen, M. (Speaker), Männistö, L. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker), Nummenmaa, E. (Speaker) & Vuolteenaho, K. (Speaker)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  Laavola, M. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor), Nieminen, R. (Contributor) & Moilanen, E. (Contributor)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  Scotece, M. (Contributor), Koskinen-Kolasa, A. (Contributor), Pemmari, A. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis

  Pemmari, A. (Speaker), Syvänen, T. (Speaker), Hämäläinen, M. (Speaker), Moilanen, T. (Speaker), Vuolteenaho, K. (Speaker) & Moilanen, E. (Speaker)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• Väitöskirjan esitarkastus

  Vuolteenaho, K. (Pre-examiner or opponent of dissertation)

  30 Aug 2018

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  26 Apr 2018

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a factor and drug target in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)

  26 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis

  Pemmari, A. (Speaker), Hämäläinen, M. (Speaker), Leppänen, T. (Speaker), Moilanen, E. (Speaker) & Vuolteenaho, K. (Speaker)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates interleukin-6 expression in chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis (OA): Retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in OA patients

  Scotece, M. (Contributor), Koskinen-Kolasa, A. (Contributor), Moilanen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Adipokine retinol binding protein 4 is expressed in chondrocytes and correlates with matrix metalloproteinases in osteoarthritis patients

  Scotece, M. (Contributor), Koskinen-Kolasa, A. (Contributor), Moilanen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  21 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  21 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Väitöskirjan esitarkastus

  Vuolteenaho, K. (Pre-examiner or opponent of dissertation)

  29 Jan 2018

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes

  Nummenmaa, E. (Speaker), Hämäläinen, M. (Speaker), Pemmari, A. (Speaker), Moilanen, L. (Speaker), Nieminen, R. (Speaker), Moilanen, T. (Speaker), Vuolteenaho, K. (Speaker) & Moilanen, E. (Speaker)

  25 Jan 2018

  Activity: Talk or presentation › Conference presentation